SOPs from EUCAST
EUCAST SOPs
- SOP 1.4 Setting breakpoints for new antimicrobial agents (2 December 2021)
Previous versions 1.1; 1.2; 1.3 - SOP 2.4 Harmonising breakpoints for existing antimicrobial agents (2 December 2021)
Previous versions: 2.1 2.2; 2.3 - SOP 3.3 Review and revision of breakpoints (21 July, 2022)
Previous versions, 3.1; 3.2; 3.3 - SOP 4.6 EUCAST Committees and subcommittees (26 September, 2022)
Previous versions: 4.0; 4.1; 4.2; 4.3; 4.4; 4.5 - SOP 5.3 EUCAST and the interaction with NACs (2 December 2021)
Previous versions: 5.0; 5.1; 5.2 - SOP 6.3 Organisation and maintenance of EUCAST websites (2 December, 2021)
- Previous versions 6.0; 6.1; 6.2
- SOP 7.3 Preparation and handling of EUCAST minutes (21 July, 2022)
Previous versions: 7.0, 7.1; 7.2 - SOP 8.3 Format and updates of documents (21 July, 2022)
Previous versions: 8.0; 8.1; 8.2 - SOP 9.3 Procedure for establishing zone diameter breakpoints and quality control criteria
for new antimicrobial agents (21 July, 2022) Previous, 9.0; 9.1; 9.2 - SOP 10.2 MIC distributions and the setting of epidemiological cut-off (ECOFF) values (2 December 2021)
Previous versions: 10.0; 10.1 - SOP 11.0 Procedure for optimizing disk contents (potencies) for disk diffusion testing
of antimicrobial agents using harmonized CLSI and EUCAST criteria (13 July, 2020) - SOP 12.0 Process for submitting disk content (potency) data for joint CLSI and EUCAST
working group review and approval (21 September, 2023). - SOP 13.0 Procedure for confirming the acceptability of Mueller-Hinton agar sources
for subsequent use in CLSI and/or EUCAST studies to establish disk diffusion quality
control ranges (21 September, 2023).- Excel template for registering trial data (22 August, 2023)
Questions and comments on SOPs
